deltatrials
Unknown OBSERVATIONAL NCT05078840

PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors

Treatment of Patients With Diffuse Large B-cell Non-Hodgkins Lymphoma in Stages I and II Without Risk Factors, Adapted to the Response Evaluated With PET CT (Positron Emission Computed Tomography)

Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda

Conditions Lymphoma, Non-Hodgkin's, Adult
Interventions Evaluation of first line treatment in patients with stage I and II LBCL
Updated 8 times since 2021 Last updated: Jan 8, 2024 Started: Jun 1, 2021 Primary completion: Jun 1, 2024 Completion: Jun 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05078840, this observational or N/A phase trial focuses on Lymphoma, Non-Hodgkin's, Adult and remains ongoing. Sponsored by Grupo Argentino de Tratamiento de la Leucemia Aguda, it has been updated 8 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Nov 2021 – ~Sep 2022 · 10 months · monthly snapshotRecruiting~Sep 2022 – ~Feb 2023 · 5 months · monthly snapshotRecruiting~Feb 2023 – ~Feb 2024 · 12 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Feb 2026 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2025 — Feb 2026 [monthly]

    Recruiting

  3. Sep 2024 — Sep 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Feb 2024 — Jul 2024 [monthly]

    Recruiting

▶ Show 3 earlier versions

  1. Feb 2023 — Feb 2024 [monthly]

    Recruiting

  2. Sep 2022 — Feb 2023 [monthly]

    Recruiting

  3. Nov 2021 — Sep 2022 [monthly]

    Recruiting

    First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Grupo Argentino de Tratamiento de la Leucemia Aguda
Data source: Grupo Argentino de Tratamiento de la Leucemia Aguda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations